Literature DB >> 351395

Inhibition of normal murine hematopoiesis by leukemic cells.

P J Quesenberry, J M Rappeport, A Fountebouni, R Sullivan, K Zuckerman, M Ryan.   

Abstract

Inhibition of normal mouse hemopoietic stem cells by leukemic cells (C1498) was observed with use of in vitro agar and in vivo diffusion-chamber cultures. The C1498 cells were unresponsive to colony-stimulating activity, and, above a critical threshold, they inhibited normal granulocyte progenitors in agar culture. C1498 cells added to normal marrow in diffusion chambers progressively reduced granulocyte progenitors. The larger, more rapidly growing, C1498 cells showed the most inhibitory effect. Transmembrane culture of C1498 cells adjacent to normal marrow in double diffusion chambers for five to 14 days led to reduction of recovery of granulocyte progenitors (72 +/- 7 per cent of control) and pluripotent stem cells (45 +/- 7 per cent of control) from the normal marrow chambers. These results indicate that leukemic mouse cells inhibit normal mouse-marrow stem cells by releasing a diffusible substance, and this inhibition occurs primarily at the level of the pluripotent stem cell.

Entities:  

Mesh:

Year:  1978        PMID: 351395     DOI: 10.1056/NEJM197807132990204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  6 in total

1.  Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.

Authors:  I Olsson; T Olofsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

2.  Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.

Authors:  H D Preisler; A Raza; M Barcos
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

3.  Hypoplastic acute leukemia: description of eight cases and search for hematopoietic inhibiting activity.

Authors:  R de Bock; M de Jonge; M Korthout; E Wouters; D van Bockstaele; M van der Planken; M Peetermans
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

4.  Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor.

Authors:  J W Chiao; M Heil; Z Arlin; J D Lutton; Y S Choi; K Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model.

Authors:  Alexia Mopin; Virginie Driss; Carine Brinster
Journal:  J Vis Exp       Date:  2016-10-14       Impact factor: 1.355

6.  Hypocellular acute myeloid leukemia with bone marrow necrosis in young patients: two case reports.

Authors:  Deepali Jain; Tejinder Singh; Naresh Kumar
Journal:  J Med Case Rep       Date:  2009-01-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.